Sustained virological response after ten days of triple anti-hepatitis C virus (HCV) therapy with telaprevir plus pegylated interferon and ribavirin in an HIV/HCV co-infected cirrhotic woman

Sustained virological response after ten days of triple anti-hepatitis C virus (HCV) therapy with telaprevir plus pegylated interferon and ribavirin in an HIV/HCV co-infected cirrhotic woman

The introduction of first-generation protease inhibitors for the treatment of chronic hepatitis C in subjects infected with hepatitis C virus (HCV) genotype 1 has significantly improved the sustained virological response (SVR) rate. As liver cirrhosis reduces the probability of achieving SVR, curren...

Full description

Bibliographic Details
Main Authors: Hamid Hasson, Emanuela Messina, Marco Merli, Liviana Della Torre, Giulia Morsica, Sabrina Bagaglio, Adriano Lazzarin, Caterina Uberti-Foppa
Format: Article
Language:English
Published: Elsevier 2014-12-01
Series:International Journal of Infectious Diseases
Subjects:
Telaprevir
HIV/HCV co-infection
Liver cirrhosis
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971214016270

Similar Items

Similar Items